Upcoming IPOs: One SME public difficulty, 4 new listings scheduled for subsequent week; examine listing right here

The first market is all set to take sigh of breather as just one preliminary public providing (IPO) within the small and medium enterprise (SME) section shall be opening for subscription subsequent week.

Other than new points, the first market may also witness 4 new listings within the coming week.

“IPO mop-up for the calendar 12 months 2025 may attain Rs. 2 trillion, this is because of quite a few multinational companies itemizing in India because of strategic benefits. This has lent a world dimension to the Indian Capital Market. Components like lowered capital prices, a wider client market, and the presence of a sturdy regulatory regime have inspired international gamers to contemplate Indian markets for his or her fairness choices. A number of marquee corporations are awaiting SEBI’s nod for IPO itemizing like client equipment main LG Electronics India, IT agency Hexaware Applied sciences, mortgage lender HDB Monetary Providers and electrical two-wheeler agency Ather Power,” mentioned Mahavir Lunawat, Group Founder & Managing Director of Pantomath Monetary Providers Group.

Lunawat additional added, “The general market sentiment is anticipated to be bullish in 2025, with excessive subscription charges indicating robust demand for shares. Additional, regulatory assist from SEBI, together with streamlined compliance processes, is enhancing market stability and investor confidence encouraging each retail and institutional participation.

In abstract, the IPO panorama of 2025 seems promising, with expectations of great progress within the variety of choices and the capital raised throughout varied sectors.”

Here is an inventory of IPOs which is able to stay open for subscription subsequent week –

NAPS International India IPO

NAPS International India IPO opens for subscription on March 4 and closes on March 6. The IPO is a set value difficulty of ₹11.88 crore and is fully a contemporary difficulty of 13.20 lakh shares.

The IPO value band has been set at ₹90 per share. Aryaman Monetary Providers Restricted is the book-running lead supervisor of the NAPS International India IPO, whereas Cameo Company Providers Restricted is the registrar for the difficulty. The market maker for NAPS International India IPO is Aryaman Capital Markets Restricted.

Balaji Phosphates IPO

Balaji Phosphates IPO bidding opened for subscription on February 28 and can shut on March 4. Balaji Phosphates IPO is a guide constructed difficulty of ₹50.11 crore and is a mix of contemporary difficulty of 59.40 lakh shares aggregating to ₹41.58 crore and supply on the market of 12.18 lakh shares aggregating to ₹8.53 crore.

Balaji Phosphates IPO value band is ready at ₹66 to ₹70 per share. Arihant Capital Markets Ltd is the book-running lead supervisor of the Balaji Phosphates IPO, whereas Skyline Monetary Providers Personal Ltd is the registrar for the difficulty. The market maker for Balaji Phosphates IPO is Nnm Securities Personal Restricted.

New Listings –

Beezaasan Explotech IPO: The allotment for Beezaasan Explotech IPO was finalized on Thursday, February 27. The IPO shall be listed on BSE SME on March 3.

Nukleus Workplace Options IPO: The allotment for Nukleus Workplace Options IPO was finalized on Friday, February 28. The SME IPO shall be listing on BSE SME with a tentative itemizing date fastened as Tuesday, March 4.

Shreenath Paper IPO: The allotment for the Shreenath Paper IPO is anticipated to be finalized on Monday, March 3. The SME IPO shall be listing on BSE SME with a tentative itemizing date fastened as Wednesday, March 5.

Balaji Phosphates IPO: The allotment for the Balaji Phosphates IPO is anticipated to be finalized on Wednesday, March 5. Balaji Phosphates IPO shall be listing on NSE SME with a tentative itemizing date fastened as Friday, March 7.

Disclaimer: This story is for academic functions solely. The views and proposals above are these of particular person analysts or broking corporations, not Mint. We advise buyers to examine with licensed consultants earlier than making any funding choices.